The FLOWER study is a nationwide, virtual study looking at how rare diseases affect people over time. It aims to collect and organize health information for many rare conditions, including Alpha-Thalassemia, Beta-Thalassemia, Amyloidosis, Amyotrophic Lateral Sclerosis (ALS), and Creutzfeldt-Jakob Disease (CJD). You can join if you have a known or suspected rare disease. The study will track how long people live, the safety of their medications, and changes in their development over five years. The current status of the study is unclear.

Study design

This is an observational study planning to enroll 1000 participants. It is not a drug trial, but rather collects real-world health information.

What's involved

You would provide electronic consent and sign a medical records release. Your medical records will be collected from various sources, and you may optionally provide them yourself.

Compensation

Not stated in the trial record.

Follow-up

Your overall survival, medication safety, and developmental milestones will be measured for 5 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.